ライフサイエンスコーパス: considerations for

1 rectomy on living donors have been important considerations for 60 years.

2 We highlight knowledge gaps, considerations for addressing these knowledge gaps, and

3 ly and late sustained VT/VF raises important considerations for aggressive monitoring beyond 48 hours

4 rences among these methods lead to important considerations for all steps of genomics studies, from t

5 Special considerations for allelic inclusion are treated in the

6 om other ambulatory practices and has unique considerations for an effective administrative structure

7 To evaluate design considerations for an osteoporosis large simple trial (L

8 s; 9) treatment for acute HIV infection; 10) considerations for antiretroviral therapy among adolesce

9 ntiretroviral therapy among adolescents; 11) considerations for antiretroviral therapy among pregnant

10 enefit ratio and safety issues are important considerations for any new emerging therapies.

11 Implications for risk assessment and considerations for application of multi-ratio equilibriu

12 ronic and photonic materials with burgeoning considerations for biological applications; however, the

13 -1 pathway blockade, highlighting particular considerations for biological mechanisms, clinical trial

14 with acetals is introduced, and mechanistic considerations for both MAP methods are described.

15 ging as redox-active proteins require design considerations for both the reduced and oxidized states

16 therapeutic outcomes are, however, important considerations for both treatment options.

17 ought to underlie hunger in order to outline considerations for bridging the gap between homeostatic

18 itating mental health outcomes are important considerations for capturing the overall burden of the d

19 cardiac complications, and provides clinical considerations for cardiac evaluation and follow-up.

20 Considerations for cardiac imaging in pregnancy are also

21 are addressed in addition to the many other considerations for caring for this group of complex pati

22 Here, we review the major considerations for carrying out and interpreting results

23 egulatory mechanisms for CART and additional considerations for CART's role in brain.

24 atch effects and genomic waves are important considerations for case-parent studies of de novo CNV, a

25 verse events; 7) interruption of therapy; 8) considerations for changing therapy and available therap

26 ghts these differences and discusses special considerations for cholesterol management in the adolesc

27 ring and distribution processes are critical considerations for clinical application that should be c

28 increase sleep quantity and consistency; and considerations for clinical care to address sleep.

29 This scientific statement presents considerations for clinical management regarding the ass

30 In this viewpoint, we provide considerations for clinical pharmacology research to pro

31 linical practice has highlighted interesting considerations for clinical trial design and opened up o

32 e explore potential hypotheses and important considerations for clinical trial designs.

33 Considerations for clinical trials of restorative therap

34 orders among adolescents, highlights general considerations for co-occurring disorders treatment, rev

35 herapeutic discovery and provide theoretical considerations for combining orthogonal cancer therapies

36 Considerations for conducting future birth cohort studie

37 Four components (3-6) are assembled with considerations for control of absolute and relative ster

38 de by outlining some of the important design considerations for controlling particle shape as learned

39 arize this work by proposing a set of design considerations for controlling the growth and final shap

40 In the review, we provide considerations for correction of organelle functions in

41 with other assessments, to discuss personnel considerations for CPX laboratories, and to provide reco

42 ill patients has highlighted other important considerations for critically ill patients and evaluated

43 scopy data for targeted milling and critical considerations for cryo-ET data acquisition of the lamel

44 methodologies used across other fields, key considerations for data integration models in congenital

45 tors that influence lactation and/or HMC; 3) considerations for data quality, including addressing sa

46 Two important considerations for delivery are the quantity of delivere

47 level technologies, and discuss some general considerations for deploying mass cytometry in the conte

48 by discussing some of the related pragmatic considerations for deploying the first generation of a '

49 We discuss important considerations for designing and evaluating ensemble FRE

50 through different mechanisms prompts future considerations for designing antibiotics against resista

51 A in biomolecular condensation and highlight considerations for designing condensate reconstitution e

52 s and highlight key technical and conceptual considerations for developing new safer and more effecti

53 Prediction modeling thus requires unique considerations for development, validation, and updating

54 techniques and the influence of nutritional considerations for diabetes management are also discusse

55 he extracellular matrix, describe the design considerations for different tissues and discuss the imp

56 See the Clinical Considerations for discussion of adequacy of prior scree

57 See the Clinical Considerations for discussion of cytology method, HPV te

58 in African Americans and to highlight unique considerations for disease prevention and management.

59 ted data, using a linear model that included considerations for disease, age, sex, and tissue.

60 Among the most important considerations for donation after circulatory death (DCD

61 This perspective outlines considerations for each of these main points and suggest

62 Thus, weighing all considerations for each patient before selecting a CD19-

63 fects of siRNA molecules, and the key design considerations for effective delivery systems has spurre

64 Important considerations for effective treatment include careful p

65 emphasizing the philosophical and practical considerations for effectively merging these two types o

66 This review highlights important considerations for engineering the microenvironment for

67 pe and duration of the disease-two important considerations for envisioned therapeutic interventions.

68 This article discusses methodological considerations for equity-oriented monitoring of UHC, an

69 In this report, we suggest methodological considerations for ESR as pertains to magnetism, sample

70 gs of transdifferentiation, disease-specific considerations for establishing a therapeutically effect

71 r-associated lncRNAs and highlight important considerations for evaluating their biological significa

72 entional therapy for acute PE and to provide considerations for evidence development for new devices

73 Clinical considerations for evidence-based treatment of borderlin

74 rimotor transformations, outlining important considerations for experimental design and considering h

75 In addition, strategic considerations for experimental design and variables wil

76 e protocol describes all steps, ranging from considerations for experimental design, Co-IP, preparati

77 method and discuss theoretical and technical considerations for experimental design.

78 ning and serological testing, return-to-work considerations for exposed or infected health care worke

79 rations, fabrication methods, and analytical considerations for flow; device features that can be com

80 We highlight specific considerations for food-related studies, such as how to

81 Considerations for formulary addition and its place in t

82 sue of coverage, as well as their underlying considerations, for four major study designs, which incl

83 Efficacy for TB Prevention study, and design considerations for future clinical trials are discussed,

84 We discuss practical considerations for future clinical trials of AKI prevent

85 Considerations for future directions in gambling researc

86 ies in management, prognostic variables, and considerations for future directions.

87 Important considerations for future research as well as potential

88 Considerations for future research to complement imaging

89 LD, identifies gaps, and discusses important considerations for future research.

90 ptualization and measurement raise important considerations for future studies attempting to identify

91 line potential methodological and conceptual considerations for future studies of lncRNAs in the hear

92 erging challenges and emphasize experimental considerations for future studies.

93 cluding potential therapeutic resistance and considerations for future therapeutic applications and t

94 iew clinical, policy, safety, and regulatory considerations for generic oncology drugs focusing on th

95 Finally, we reiterate important considerations for goal research moving forward.

96 n, and HIV infection, and discuss additional considerations for guide and screen design, as well as c

97 retargeted radioimmunotherapy, and important considerations for harnessing the pretargeting strategy

98 ine and improve their specificities, and key considerations for how to evaluate and reduce off-target

99 of modern live cell imaging and the special considerations for imaging live plant specimens.

100 radiologists to be familiar with the unique considerations for imaging women with heart disease.

101 t on mechanisms of mutation accumulation and considerations for immunotherapy.See related commentary

102 Clinical considerations for implantable bioprinted tissues are fu

103 Among several important considerations for implantation of a biomaterial, a main

104 s applications in clinical microbiology, and considerations for implementation of the method in a cli

105 cal foundations of our framework and discuss considerations for implementing its various components.

106 Lastly, some potential considerations for improvement in this field are also di

107 We also discuss technical considerations for in vivo neuroepigenome-editing experi

108 ical limit of helicity emerges from helicity considerations for individual superfluid vortex filament

109 ew summarizes important phase 3 trial design considerations for industry and provides rationale for s

110 In this review, we discuss treatment considerations for infections caused by extended-spectru

111 We argue that the risk-benefit considerations for initiating ART are not the same world

112 of the tumor microenvironment and transport considerations for intratumoral drug delivery.

113 This review aims to highlight the strategic considerations for introduction of the cyclopropane moti

114 r prognosis, mtDNA as cancer biomarkers, and considerations for investigating the role of mtDNA in ca

115 Here, we review key SAB trial design considerations for investigators, sponsors, and regulato

116 n, and epiretinal membrane, require specific considerations for IOL selection.

117 allenges of genomic footprinting, as well as considerations for its application to complex genomes.

118 oid technology, and discuss the experimental considerations for its utilization.Dual Perspectives Com

119 It should include the use of classical considerations for judging causality in human studies, a

120 nsights into assay limitations and reporting considerations for laboratories.

121 ination status and to explore methodological considerations for linked survey implementation.

122 estimate of variant concordance, identifies considerations for LP classified variants, and highlight

123 We addressed these considerations for male tree lizards (Urosaurus ornatus)

124 Considerations for management include prophylactic IOP-l

125 bes these alterations and provides practical considerations for management of medications.

126 man T-cell activation, and discuss important considerations for material design and T-cell co-culture

127 l utility and consumer appeal need to be key considerations for measures intended to be used in every

128 use conventional power, speed and volatility considerations for microelectronics may no longer exist.

129 ata and actual nursing documentation, and 4) considerations for model development and report design t

130 These are important considerations for modeling future biosphere-atmosphere

131 We also highlight considerations for modeling this dynamic tumor ecology a

132 cation primers, as well as discuss important considerations for multiplex and quantitative SHERLOCK d

133 c health laboratory setting, and it includes considerations for NGS test validation, quality control

134 Sensitivity and resolution are key considerations for NMR applications in general and for m

135 nges to nasal delivery, and drug/formulation considerations for nose to brain delivery are also discu

136 medications studied for obesity and provide considerations for obesity medication use in clinical pr

137 eneral experimental strategies and practical considerations for obtaining kinetic data of sufficient

138 We have examined these considerations for open pond systems, to identify variab

139 Next, considerations for optimal future evidence development i

140 Additionally, considerations for optimization of the DESI-MS process a

141 Quality control methods and considerations for optimizing flow conditions are detail

142 gn given the unique features of GKC therapy, considerations for optimizing stereotactic targeting and

143 Design considerations for optimizing these devices for liquid-p

144 treatment of neurogenic pulmonary edema, and considerations for organ donation.

145 Similar general considerations for out-of-operating room anesthesia equa

146 l be discussed with a particular emphasis on considerations for parents of teenagers.

147 These recent studies highlight important considerations for patient selection, SWL technique and

148 A framework of key considerations for patients with active brain metastases

149 This review summarizes clinical considerations for patients with clonal hematopoiesis, i

150 athophysiology, presentations and management considerations for patients with COVID-19 to aid clinici

151 artment syndrome (MCS) and current treatment considerations for patients with TBI given the effects o

152 ested when using the data to guide treatment considerations for patients.

153 work and describe theoretical and practical considerations for performing and interpreting SeqChIP e

154 d, this protocol includes itemized steps and considerations for performing immunocytochemistry, acqui

155 Results are important considerations for personalized care and risk stratifica

156 insecticide timing and efficacy are crucial considerations for pest management.

157 lur personal and work identities, posing new considerations for physician professionalism in the info

158 over, these findings suggest new therapeutic considerations for PI3K and/or AKT inhibitors for cancer

159 exity of connectedness in suicide, and offer considerations for policy and practice.

160 rs revisit the topic and highlight important considerations for policy-makers related to the impact o

161 ts across socioeconomic groups are important considerations for policy-makers.

162 egulating mucosal repair and raise important considerations for possible alterations in wound healing

163 A literature review was performed and considerations for pragmatic management were proposed.

164 competitive athletes importantly influences considerations for pre-participation screening strategie

165 We discuss methodological and practical considerations for preclinical modeling of additive/syne

166 hlighting anesthetic, obstetric and surgical considerations for pregnant trauma victims was performed

167 Unique considerations for PrEP implementation arise during preg

168 We also offer pathophysiological considerations for primary TCH.

169 n native human proteins we explore potential considerations for producing a specification for misinco

170 These trends are important considerations for prospective policy development and re

171 and articulated important equity and ethical considerations for protecting the health and safety of l

172 dual sensory impairment, with an emphasis on considerations for provision of appropriate hearing assi

173 These are important considerations for quantitative studies in animal models

174 ant new paradigm of cancer treatment and key considerations for rational design of nanomedicine of sy

175 It also outlines key considerations for reporting on flexible trials of EHR i

176 lated, and other features to highlight major considerations for research applying person-oriented app

177 n genomic data sets and highlights important considerations for research communities that are develop

178 Our results underscore two general considerations for researchers proposing novel types of

179 s the state of the science of CTE and raises considerations for researching and interpreting cognitiv

180 General mechanistic considerations for RNA catalysis suggest that the penalt

181 n this study, fundamental differences in the considerations for RNA interference and antisense ODNs a

182 yses, as well as including potential quality considerations for safe and reliable transportation and

183 We describe special considerations for sample preparation and digestion, mas

184 We propose a few considerations for scholars interested in joining the ev

185 ssibility, and reproducibility are important considerations for scientific publication.

186 We discuss considerations for screen design, and we present complet

187 our protocol offers a set of suggestions and considerations for screen optimization and a step-by-ste

188 management of these complications as well as considerations for sedation, analgesia, anticoagulation,

189 ty of biomarkers in drug development(,) with considerations for seeking regulatory endorsement for us

190 areas: advances in ALK testing methodology, considerations for selecting appropriate populations for

191 Key topics include considerations for selecting predictor variables, operat

192 hese systems contextualizes essential design considerations for sensors and associated platforms that

193 overy, and highlight the main challenges and considerations for setting up an NGS and bioinformatics-

194 This case offers new potential considerations for short- and long-term management of no

195 approach combines some of the most important considerations for species vulnerability in a straightfo

196 ensive list of recommendations that includes considerations for specific populations is also provided

197 We also provide technical considerations for standardization and further improveme

198 pharmacogenomics with a focus on the special considerations for study design.

199 with an accompanying description of possible considerations for study design.

200 nd are used to highlight some of the primary considerations for studying misfolded proteins associate

201 e, and function and will highlight technical considerations for studying this population.

202 rapeutic implications, and discuss practical considerations for successful application of tumor genot

203 We present several considerations for such a reduction in data collection,

204 Design considerations for such a trial should include the need

205 Putative design strategies and experimental considerations for such probes are discussed.

206 we describe theoretical and empirical design considerations for such sequencing studies, aimed at max

207 We outline some practical considerations for such simulations.

208 ominic Kwiatkowski discuss important ethical considerations for sustainable genomics research in Afri

209 lational treatments are discussed, including considerations for targeted inhibition of VEGF signaling

210 r molecular research and highlight technical considerations for the analysis of medium-sized inverteb

211 ases as well as highlighting a wide range of considerations for the analysis of transcriptomic data.

212 Considerations for the anesthetic management of patients

213 Second, we elaborate on economic considerations for the application of antiadhesion barri

214 We also raise important considerations for the assessment and evaluation of such

215 We also highlight key considerations for the assessment of the role of antibod

216 ata have been evaluated to provide practical considerations for the assessment, monitoring, and reduc

217 e spectral range, whereas the phase-matching considerations for the Brillouin process require optical

218 Considerations for the cause of this disease emphasise a

219 e will provide an overview of the regulatory considerations for the clinical development and licensur

220 In this perspective, we describe considerations for the design and development of enginee

221 early knee osteoarthritis (OA) are important considerations for the design and evaluation of therapeu

222 In this review, we discuss important considerations for the design and interpretation of clus

223 These findings highlight important considerations for the design and testing of candidate H

224 These findings are important considerations for the design of clinical trials, and mi

225 l function as a therapeutic target, some key considerations for the design of early-phase clinical tr

226 In this article, I discuss considerations for the design of such a trial in a regio

227 This paper summarizes the considerations for the design of these analytical and cl

228 of cRCTs and highlight and explain important considerations for the design, analysis, and reporting o

229 ive prevention of metachronous CRC, specific considerations for the detection of local recurrence in

230 Considerations for the development of de-escalation tria

231 One of the important considerations for the development of on-chip batteries

232 These findings raise important considerations for the development of peptide therapies

233 The key considerations for the development of such devices inten

234 ons under positive selection, both important considerations for the development of vaccines and T-cel

235 umoral cross-reactivity and discuss relevant considerations for the development of vaccines and thera

236 ith insight given on the design and material considerations for the effective integration of THz spec

237 Yet, implementation of CR may require unique considerations for the elderly and other specific popula

238 Finally, we offer recommendations and considerations for the field going forward.

239 These are useful considerations for the formulation of treatment policy (

240 e transcriptional mechanisms they employ and considerations for the future study of this important tr

241 Furthermore, primer design considerations for the G-quadruplex-generating PCR syste

242 hich the AI intervention will be integrated, considerations for the handling of input and output data

243 enefits of routine vaccination are important considerations for the inclusion of Dengvaxia into exist

244 We also offer considerations for the interpretation of ctDNA genotypin

245 domen was performed to narrow the diagnostic considerations for the lesions identified at CT.

246 argeted temperature management and practical considerations for the management of medications.

247 These results pose critical considerations for the methods used to design and evalua

248 Scaling considerations for the modern practice of combination ch

249 Our work reveals structural considerations for the nano-bio interfaces involved in l

250 toxicity and biocompatibility were important considerations for the new bioactive materials.

251 ensus recommendations and medical management considerations for the patient newly diagnosed with a le

252 , is then discussed, together with important considerations for the percutaneous closure of PVL, such

253 Air-stability is one of the most important considerations for the practical application of electrod

254 We further discuss considerations for the practical use of this tool.

255 trategies, and comment on present and future considerations for the regulatory review of diabetes dru

256 omplexity, and user perspectives will be key considerations for the roll-out of effective products.

257 We also highlight practical considerations for the selection of climate models and d

258 tual, practical, statistical, and logistical considerations for the use of microarrays in studies of

259 panded criteria donor organ utilization, and considerations for the way forward are discussed.

260 that elite athletes should receive the same considerations for their airway health as others with po

261 ents and engineering poxviruses with special considerations for their effect on M2 macrophage-contain

262 rs to clinical translation of MNPs and offer considerations for their future development.

263 se co-occurring compounds suggests important considerations for their respective biodegradation proce

264 ill review ebolavirus vaccine candidates and considerations for their use in humans and wild apes.

265 ments in these methods and discuss practical considerations for their use in imaging proteins inside

266 populations and discuss key assumptions and considerations for their use with a focus on detecting B

267 NTPs present pharmacological and mechanistic considerations for therapeutic discovery.

268 both IL-6 and IL-17 functions are important considerations for therapies of chronic viral diseases,

269 ; 4) adherence to antiretroviral therapy; 5) considerations for therapy among patients with advanced

270 re, and myocarditis), and explore management considerations for these groups, with particular emphasi

271 Here we discuss technical considerations for these high-throughput assays, togethe

272 Experts might review safety considerations for these laboratory testing/diagnostic a

273 ntaneous hyphaema and adds to the management considerations for this condition.

274 ment of such masses and comment on technical considerations for this particular ablative technique.

275 the underlying features and chemical design considerations for this polymer, and the biocompatibilit

276 pathogenesis, and diagnostic and therapeutic considerations for this previously unrecognized disease.

277 Anesthetic considerations for thoracic and thoracoscopic neurosurgi

278 We also outline the important considerations for those referencing identifiers in vari

279 after total pancreatectomy; and (5) registry considerations for TPIAT.

280 odological aspects of risk-modeling methods, considerations for translation to clinical practice, and

281 odological aspects of risk-modeling methods, considerations for translation to clinical practice, and

282 ated liver disease, with a specific focus on considerations for transplantation.

283 lly, we provide an overview of the treatment considerations for treating migraine with psychiatric co

284 lectrophysiologic substrate, require special considerations for treatment and complication avoidance.

285 Important considerations for triage test evaluation include study

286 and B cells in IPF pathogenesis, and support considerations for trials of specific B-cell-targeted th

287 in non-hematopoietic cells are important new considerations for understanding AhR-mediated changes in

288 atch-up vaccination with TCVs and highlights considerations for universal, risk-based, or phased vacc

289 a was conducted, with particular emphasis on considerations for urologic referral.

290 Finally, we discuss considerations for using alternative indicators for wate

291 In this Review, we present the unique considerations for using genotype and phenotype data fro

292 We also discuss special considerations for using IAD outside the context of a cl

293 Critical considerations for using isotopically labeled rhGH as th

294 Molecular and clinical considerations for using neoadjuvant chemotherapy in the

295 This new understanding raises important considerations for vaccine design and for the measuremen

296 es and review key computational advances and considerations for various CRISPR applications.

297 Special considerations for video-assisted thoracoscopic surgery,

298 Our results provide important considerations for viral vectors to be used in future ge

299 sting for antiretroviral drug resistance; 3) considerations for when to initiate therapy; 4) adherenc

300 We present practical handling and safety considerations for working with this reactive biomolecul